Advances in Surgery of Head and Neck Squamous Cell Carcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (20 September 2024) | Viewed by 5571
Special Issue Editor
Interests: head and neck cancer; sinonasal/skullbase tumors; translational research; tumor recurrence and distant metastasis; tumor microenvironment; tumor heterogeneity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Head and neck squamous cell carcinoma is a type of cancer that affects the tissues in the head and neck region. It can be a challenging disease to treat, but advances in surgery have made the process much more successful. Over the years, surgeons have developed new techniques and technologies that allow for more precise and effective removal of cancerous cells. This has led to better outcomes for patients and a higher likelihood of long-term survival.
Some of the key advances in surgery for head and neck squamous cell carcinoma include minimally invasive techniques, precision-image-guided surgery, and the use of robots to assist with surgery. These innovations have helped reduce complications, speed up recovery times for patients, and improve adequate resections.
Overall, the field of surgery for head and neck squamous cell carcinoma is rapidly advancing, and patients can expect to benefit from these improvements in the years to come.
In this Special Issue, we aim to collect original research articles and review articles to present and discuss data on surgical advances in head and neck squamous cell carcinoma.
Dr. José Angelito U. Hardillo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- head and neck squamous cell carcinoma
- surgery
- outcomes
- minimally invasive techniques
- precision-image-guided surgery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.